Gene · 6510
Papers3,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent advances in ASCT2 inhibitors: ligand design and therapeutic applications. | Future Med Chem | 2025 | 40819934 | PubTator, text mining | PubMed |
| Androgens drive SLC1A5-dependent metabolic reprogramming in polycystic ovary syndrome. | Nat Commun | 2025 | 40817119 | PubTator, text mining | PubMed |
| Empowering hypoxia to convert cold tumors into hot tumors for breast cancer immunotherapy. | Cell Death Discov | 2025 | 40813760 | PubTator, text mining | PubMed |
| Real-Time Tracking of ASCT2-Mediated Glutamine Uptake in Living Tumors With a Bioorthogonal Bioluminescent Probe. | Adv Sci (Weinh) | 2025 | 40783801 | PubTator, text mining | PubMed |
| Modulating the serine metabolism in human differentiated astrocytes: an integrated multi omics approach. | Front Cell Neurosci | 2025 | 40761926 | PubTator, text mining | PubMed |
| RNA Epigenetics in Cancer: Current Knowledge and Therapeutic Implications. | MedComm (2020) | 2025 | 40761481 | PubTator, text mining | PubMed |
| Cancer stem cells: landscape, challenges and emerging therapeutic innovations. | Signal Transduct Target Ther | 2025 | 40759634 | PubTator, text mining | PubMed |
| Imaging the uptake and metabolism of glutamine in prostate tumor models using CEST MRI. | Npj Imaging | 2025 | 40750673 | PubTator, text mining | PubMed |
| "Molecular pigeon" network of lncRNA and miRNA: decoding metabolic reprogramming in patients with lung cancer. | Front Oncol | 2025 | 40746614 | PubTator, text mining | PubMed |
| Effect of TP53 mutation, expression and polymorphism on the survival, immune infiltration and ferroptosis in patients with prostate cancer. | Oncol Lett | 2025 | 40740989 | PubTator, text mining | PubMed |
| Ferroptosis: a novel pharmacological mechanism against multiple myeloma. | Front Pharmacol | 2025 | 40735482 | PubTator, text mining | PubMed |
| Clinical application prospects of traditional Chinese medicine as adjuvant therapy for metabolic reprogramming in colorectal cancer. | Front Immunol | 2025 | 40735327 | PubTator, text mining | PubMed |
| Dynamic Mechanisms of Neutral Amino Acid Exchanger ASCT2 Transporting Substrate Glutamine. | J Chem Inf Model | 2025 | 40720984 | PubTator, text mining | PubMed |
| Disruption of glutamine transport uncouples the NUPR1 stress-adaptation program and induces prostate cancer radiosensitivity. | Cell Commun Signal | 2025 | 40707944 | PubTator, text mining | PubMed |
| ASCT2 inhibits HIV-1 infectivity by promoting the incorporation of a gp160/ASCT2 complex into virions. | mBio | 2025 | 40689623 | PubTator, text mining | PubMed |
| Metabolomic Profiling Reveals Key Metabolic Alterations in MCF7 Tamoxifen-Resistant Cells Following EPAS1 Inhibition. | J Proteome Res | 2025 | 40675783 | PubTator, text mining | PubMed |
| Multi-Omics Analysis and Real-World Data Validation of Serine Metabolism-Related Genes in Colorectal Cancer. | J Cell Mol Med | 2025 | 40660426 | PubTator, text mining | PubMed |
| SLC1A5-dependent glutamine uptake in hepatocytes promotes liver regeneration. | Hepatol Commun | 2025 | 40658789 | PubTator, text mining | PubMed |
| Clinical Utility of Fluciclovine PET in BNCT for Recurrent High-grade Glioma. | Clin Nucl Med | 2025 | 40644581 | PubTator, text mining | PubMed |
| Beyond the tumor: Enhancing pancreatic cancer therapy through glutamine metabolism and innovative drug delivery. | J Cell Commun Signal | 2025 | 40641572 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6510/papers?page=9